Written and maintained by CASRAI Editorial Board
Last updated
Short answer: IEC 60601-1 is the international general standard for the basic safety and essential performance of medical electrical equipment. It is Edition 3.0 (published 2005-12-15), amended in 2012 and 2020, and where a particular standard exists for a device type it is not meant to be used alone.
Definition and scope
The IEC webstore titles the standard “Medical electrical equipment – Part 1: General requirements for basic safety and essential performance.” Its own summary says it contains requirements concerning basic safety and essential performance that are generally applicable to medical electrical equipment. For certain types of equipment, those requirements are supplemented or modified by a collateral or particular standard, and “where particular standards exist, this standard should not be used alone.”
The FDA’s recognized-consensus-standards entry for the US national adoption (ANSI AAMI ES60601-1) describes the same scope in its own terms: the basic safety and essential performance of ME equipment and ME systems. It also notes that the standard does not cover hazards inherent in the intended physiological function of the equipment, apart from two named clauses (7.2.13 and 8.4.1), and that it may apply to equipment that compensates for or alleviates disease, injury or disability.
How it is used in practice
The standard works as the base of a family. The general standard sets requirements that apply broadly; collateral standards (numbered 60601-1-x) add cross-cutting requirements; particular standards (numbered 60601-2-x) add or modify requirements for a specific kind of equipment. A device is therefore normally assessed against the general standard together with the particular standard for its type, which is why one document alone rarely answers a supplier question.
The two concepts in the title do the organising work. Essential performance, as commonly defined in industry glossaries, is the performance whose loss or degradation beyond manufacturer-specified limits results in unacceptable risk, and it is determined from the intended use and the manufacturer’s risk management. For the risk-management side, see ISO 14971 and the risk management file.
Which edition applies? IEC, FDA recognition and the 2028 stability date
Several editions and copies are in circulation, and they are not interchangeable labels. The table lists only what the IEC webstore and the FDA standards database state.
| Item | What the source states | Source |
|---|---|---|
| IEC 60601-1:2005, Edition 3.0 | Published 2005-12-15; stability date 2028 | IEC webstore |
| Amendment 1 | Year 2012 | IEC webstore |
| Amendment 2 | Year 2020 | IEC webstore |
| Consolidated copy IEC 60601-1:2005+AMD1:2012+AMD2:2020 CSV | Incorporates the amendments; also includes the corrigenda of December 2006, December 2007 and December 2022 and the interpretation sheets of April 2008, January 2009 and May 2013 | IEC webstore |
| US adoption ANSI AAMI ES60601-1:2005/(R)2012 & A1:2012 (consolidated text, including AMD2:2021) | FDA recognition number 19-46; date of entry 05/30/2022; recognized as a complete standard; included in the ASCA program | FDA standards database |
| IEC 60601-1 Edition 3.2 (2020-08) consolidated version | Listed in the FDA entry as the related recognition number 19-49 | FDA standards database |
The FDA entry shows a last-updated date of 09/28/2026. The IEC webstore also lists an “IEC 60601-1:2026 SER” series pack of the Medical electrical equipment all-parts series, published 2026-07-10 by TC 62/SC 62A. The record describes a pack of components for the series, so a supplier’s reference to the standard should still name the edition or amendment level it was tested to.
What is outside IEC 60601-1?
Laboratories often meet this standard when buying instruments, so the exclusions matter as much as the scope. According to the FDA entry, the scope does not include:
- In vitro diagnostic equipment that does not meet the definition of ME equipment, which falls under the IEC 61010 series;
- The implantable parts of active implantable medical devices, covered by the ISO 14708 series;
- Medical gas pipeline systems, covered by ISO 7396-1.
A bench analyser that only processes specimens is therefore usually a question for IEC 61010, while equipment applied to a patient is a question for 60601. Whether a given product is a medical device at all is a regulatory question; see what is a medical device.
Where it matters for labs, clinics and supply decisions
Treat the following as questions to put to a supplier, not as requirements drawn from any one source. Each maps to a fact above.
- Which edition and amendment level was the device assessed against (2005 base, 2012, 2020, or the consolidated Edition 3.2)?
- Which particular standard applies to this equipment type, and was the device assessed against it as well?
- Is the product intended as medical electrical equipment, or does it fall under an exclusion such as IEC 61010 for in vitro diagnostic instruments?
- Which collateral standards were applied? Monitoring and diagnostic equipment is commonly tested against 60601-1 and the electromagnetic compatibility collateral 60601-1-2 together; see choosing diagnostic and patient monitoring equipment.
- Does the target market recognize the edition cited? FDA lists its recognized US adoption and the IEC Edition 3.2 consolidated version as separate entries.
For the maintenance side of the same equipment, see biomedical equipment maintenance, and for the European marking route, CE marking.
Common misunderstandings
“IEC 60601-1 certifies a device as safe.”
The standard sets requirements for basic safety and essential performance. It is a reference that a manufacturer or test body assesses against, not a mark carried by the standard itself, and it does not cover hazards inherent in the intended physiological function except in two named clauses.
“The general standard is enough on its own.”
The IEC summary states the opposite for equipment that has a particular standard: it should not be used alone.
“There is one current version.”
The base publication, two amendments, a consolidated copy, a US national adoption and a 2026 series pack all coexist. The IEC webstore lists a stability date of 2028 for the publication.
“It applies to every instrument in a laboratory.”
Instruments that are in vitro diagnostic equipment outside the ME equipment definition are directed to IEC 61010 by the FDA entry.
Frequently asked questions
What is IEC 60601-1?
It is the general standard for basic safety and essential performance of medical electrical equipment, Edition 3.0 published 2005-12-15 by IEC, with amendments in 2012 and 2020.
Is IEC 60601-1 the same as ANSI AAMI ES60601-1?
The ANSI AAMI ES60601-1 document is the US national adoption that FDA recognizes under number 19-46. The FDA entry also lists the IEC 60601-1 Edition 3.2 consolidated version, recognition number 19-49, as a related reference.
What is essential performance?
Performance whose loss or degradation beyond the manufacturer’s specified limits results in unacceptable risk, determined from intended use and risk management.
What does the 2028 stability date mean?
The IEC webstore lists 2028 as the publication’s stability date. It is a date shown on the record; it does not by itself withdraw the standard.
Sources
- IEC webstore, IEC 60601-1:2005 and consolidated version record: https://webstore.iec.ch/en/publication/2606 (checked 2026-10-29).
- IEC webstore, IEC 60601-1:2026 SER series pack: https://webstore.iec.ch/en/publication/2603 (checked 2026-10-29).
- US FDA, Recognized Consensus Standards database, ANSI AAMI ES60601-1 (Recognition No. 19-46): https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/detail.cfm?standard__identification_no=43309 (page updated 09/28/2026; checked 2026-10-29).
